Publication: Consensus statement on the management of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Asia
Issued Date
2015-04-01
Resource Type
ISSN
1752699X
17526981
17526981
Other identifier(s)
2-s2.0-84926337206
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical Respiratory Journal. Vol.9, No.2 (2015), 129-142
Suggested Citation
Bin Cao, Thuan T. Tan, Edwin Poon, Jann Tay Wang, Suresh Kumar, Chong H.Kin Liam, Kamal Ahmed, Patrick Moral, Haibo Qiu, Marie Yvette Barez, Latre Buntaran, Oloan E. Tampubolon, Visanu Thamlikitkul Consensus statement on the management of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Asia. Clinical Respiratory Journal. Vol.9, No.2 (2015), 129-142. doi:10.1111/crj.12134 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/36482
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Consensus statement on the management of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Asia
Other Contributor(s)
Beijing Red Cross Chaoyang Hospital
Singapore General Hospital
Private Practice
National Taiwan University Hospital
Hospital Sungai Buloh
University of Malaya
Liaquat National Hospital
University of Santo Tomas, Manila
Southeast University
Davao Doctors Hospital
'Harapan Kita' Heart Hospital
Intensivist
Mahidol University
Singapore General Hospital
Private Practice
National Taiwan University Hospital
Hospital Sungai Buloh
University of Malaya
Liaquat National Hospital
University of Santo Tomas, Manila
Southeast University
Davao Doctors Hospital
'Harapan Kita' Heart Hospital
Intensivist
Mahidol University
Abstract
© 2014 John Wiley & Sons Ltd. Nosocomial pneumonia (NP; encompassing hospital-acquired, health care-associated and ventilator-associated pneumonia) is one of the most common nosocomial infections and is associated with a mortality rate of 18.7%-40.8% in Asian countries. The burden of methicillin-resistant Staphylococcus aureus (MRSA) infections in Asia is high, and approximately 13% of NP cases in Asia are caused by this pathogen. Evidence regarding optimal management of MRSA NP continues to evolve and is complicated by the fact that a significant proportion of cases are likely to be caused by isolates with reduced susceptibility to the main therapeutic agent, vancomycin. The Asian Consensus Taskforce on MRSA Nosocomial Pneumonia has developed this statement to provide consensus points on diagnosis, antimicrobial treatment and prevention strategies for MRSA NP in the Asian context, based on our review of Asian data, previous international guidelines and recent scientific evidence.